Oral-only Antibiotics for Bone and Joint Infections in Children
Conditions: Osteomyelitis; Septic Arthritis; Bone Infection; Joint Infection; Bone and Joint Infection Interventions: Drug: Oral co-amoxiclav or oral dicloxacillin only; Drug: IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin Sponsors: Rigshospitalet, Denmark; The research foundation of Copenhagen University Hospital, Rigshospitalet; Copenhagen Health Science Partners; Innovation Fund Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2020 Category: Research Source Type: clinical trials
Oral-only Antibiotics for Bone and Joint Infections in Children
Conditions: Osteomyelitis; Septic Arthritis; Bone Infection; Joint Infection; Bone and Joint Infection Interventions: Drug: Oral co-amoxiclav or oral dicloxacillin only; Drug: IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin Sponsors: Rigshospitalet, Denmark; The research foundation of Copenhagen University Hospital, Rigshospitalet; Copenhagen Health Science Partners; Innovation Fund Denmark Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2020 Category: Research Source Type: clinical trials
Oral-only Antibiotics for Bone and Joint Infections in Children
Conditions: Osteomyelitis; Septic Arthritis; Bone Infection; Joint Infection; Bone and Joint Infection Interventions: Drug: Oral co-amoxiclav or oral dicloxacillin only; Drug: IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin Sponsors: Rigshospitalet, Denmark; The research foundation of Copenhagen University Hospital, Rigshospitalet; Copenhagen Health Science Partners; Innovation Fund Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2020 Category: Research Source Type: clinical trials
Acute Non-severe Osteomyelitis in Children - Outpatient Management Strategy With Oral Antibiotic Therapy Compared to a Standard Strategy With Conventional Hospitalization and Intravenous Antibiotic Therapy: a Randomized Open-label Non-inferiority Study With Bayesian and Medical-economic Analyses.
Condition: Osteomyelitis Intervention: Other: therapeutic strategy Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2020 Category: Research Source Type: clinical trials